Nurix Therapeutics, Inc. Profile Avatar - Palmy Investing

Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's t…

Biotechnology
US, San Francisco [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of NRIX's Analysis
CIK: 1549595 CUSIP: 67080M103 ISIN: US67080M1036 LEI: - UEI: -
Secondary Listings
NRIX has no secondary listings inside our databases.